508 related articles for article (PubMed ID: 31775767)
1. Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts.
Gleeson D; Lexchin J; Labonté R; Townsend B; Gagnon MA; Kohler J; Forman L; Shadlen KC
Global Health; 2019 Nov; 15(Suppl 1):78. PubMed ID: 31775767
[TBL] [Abstract][Full Text] [Related]
2. The Regional Comprehensive Economic Partnership, Intellectual Property Protection, and Access to Medicines.
Townsend B; Gleeson D; Lopert R
Asia Pac J Public Health; 2016 Nov; 28(8):682-693. PubMed ID: 27920239
[TBL] [Abstract][Full Text] [Related]
3. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
4. USMCA (NAFTA 2.0): tightening the constraints on the right to regulate for public health.
Labonté R; Crosbie E; Gleeson D; McNamara C
Global Health; 2019 May; 15(1):35. PubMed ID: 31088499
[TBL] [Abstract][Full Text] [Related]
5. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
6. Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review.
Islam MD; Kaplan WA; Trachtenberg D; Thrasher R; Gallagher KP; Wirtz VJ
Global Health; 2019 Dec; 15(1):88. PubMed ID: 31888688
[TBL] [Abstract][Full Text] [Related]
7. The ethics of intellectual property rights in an era of globalization.
Shah AK; Warsh J; Kesselheim AS
J Law Med Ethics; 2013; 41(4):841-51, Table of Contents. PubMed ID: 24446942
[TBL] [Abstract][Full Text] [Related]
8. The high price of "free" trade: U.S. trade agreements and access to medicines.
Lopert R; Gleeson D
J Law Med Ethics; 2013; 41(1):199-223. PubMed ID: 23581666
[TBL] [Abstract][Full Text] [Related]
9. Addressing legal and political barriers to global pharmaceutical access: options for remedying the impact of the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) and the imposition of TRIPS-plus standards.
Cohen-Kohler JC; Forman L; Lipkus N
Health Econ Policy Law; 2008 Jul; 3(Pt 3):229-56. PubMed ID: 18634618
[TBL] [Abstract][Full Text] [Related]
10. The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries.
Son KB; Lee TJ
Glob Public Health; 2018 Sep; 13(9):1169-1178. PubMed ID: 28585477
[TBL] [Abstract][Full Text] [Related]
11. Trade, TRIPS, and pharmaceuticals.
Smith RD; Correa C; Oh C
Lancet; 2009 Feb; 373(9664):684-91. PubMed ID: 19167054
[TBL] [Abstract][Full Text] [Related]
12. The Trans-Pacific Partnership: Is It Everything We Feared for Health?
Labonté R; Schram A; Ruckert A
Int J Health Policy Manag; 2016 Aug; 5(8):487-496. PubMed ID: 27694662
[TBL] [Abstract][Full Text] [Related]
13. Trans-Pacific Partnership Provisions in Intellectual Property, Transparency, and Investment Chapters Threaten Access to Medicines in the US and Elsewhere.
Baker BK
PLoS Med; 2016 Mar; 13(3):e1001970. PubMed ID: 26954325
[TBL] [Abstract][Full Text] [Related]
14. Intellectual property and access to medicines: mapping public attitudes toward pharmaceuticals during the United States-Mexico-Canada Agreement (USMCA) negotiation process.
Wong ASY; Cole CB; Kohler JC
Global Health; 2021 Aug; 17(1):92. PubMed ID: 34416883
[TBL] [Abstract][Full Text] [Related]
15. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
16. Trade-Related Aspects of Intellectual Property Rights Flexibilities and Public Health: Implementation of Compulsory Licensing Provisions into National Patent Legislation.
McGIVERN L
Milbank Q; 2023 Dec; 101(4):1280-1303. PubMed ID: 37646392
[TBL] [Abstract][Full Text] [Related]
17. A conceptual framework for investigating the impacts of international trade and investment agreements on noncommunicable disease risk factors.
Schram A; Ruckert A; VanDuzer JA; Friel S; Gleeson D; Thow AM; Stuckler D; Labonte R
Health Policy Plan; 2018 Jan; 33(1):123-136. PubMed ID: 29106574
[TBL] [Abstract][Full Text] [Related]
18. The Trans Pacific Partnership Agreement and Pharmaceutical Regulation in Canada and Australia.
Lexchin J; Gleeson D
Int J Health Serv; 2016 Oct; 46(4):597-613. PubMed ID: 27516183
[TBL] [Abstract][Full Text] [Related]
19. The Trans Pacific Partnership Agreement and access to HIV treatment in Vietnam.
Moir HVJ; Tenni B; Gleeson D; Lopert R
Glob Public Health; 2018 Apr; 13(4):400-413. PubMed ID: 27841097
[TBL] [Abstract][Full Text] [Related]
20. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
